Skip to main content
GIVE 'EM L: WHY LEQVIO Patient Profiles

What treatment choice fits the needs of these patients?

There’s more to know about LEQVIO

See how LEQVIO might help patients like these

ACE, angiotensin-converting enzyme; ACS, acute coronary syndrome; ASCVD, atherosclerotic cardiovascular disease; BMI, body mass index; CAC, coronary artery calcium; CCTA, coronary computed tomography angiography; CV, cardiovascular; GLP-1, glucagon-like peptide-1; HCP, health care professional; LDL-C, low-density lipoprotein cholesterol; STEMI, ST-elevation myocardial infarction.

References: 1. Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139(25):e1082-e1143. doi:10.1161/CIR.0000000000000625 2. Olvera Lopez E, Ballard BD, Jan A. Cardiovascular Disease. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. Updated August 22, 2023. Accessed March 10, 2026. https://www.ncbi.nlm.nih.gov/books/NBK535419/ 3. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel Ill) final report. Circulation. 2002;106(25):3143-3421. 4. White paper: Prioritizing LDL-Cholesterol Control. Family Heart Foundation. Published September 30, 2023. Accessed April 30, 2026. https://familyheart.org/prioritizing-ldl-cholesterol-control